Stay updated on Distribution of BI 754111 in Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Distribution of BI 754111 in Cancer Patients Clinical Trial page.

Latest updates to the Distribution of BI 754111 in Cancer Patients Clinical Trial page
- Check6 days agoChange DetectedVersion history now includes Results Posted, More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with a Document Section update and Revision: v3.3.4.SummaryDifference1.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Results Submission Events (1) and Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page history.SummaryDifference0.3%

- Check42 days agoChange DetectedThe Record History shows a new version where the status changes from 'No Results Posted' to 'Results Submitted'. This indicates that results for the study have been submitted.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page history shows an addition of Revision: v3.3.2 and a removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status that previously appeared on the page. This change does not affect core trial content, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedUpdates to the Study Status and Recruitment Status sections, including revised locations and contact details. The changes reflect the current state of the trial and who can participate.SummaryDifference0.1%

Stay in the know with updates to Distribution of BI 754111 in Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Distribution of BI 754111 in Cancer Patients Clinical Trial page.